Roivant Sciences, Inc

Website
451 D St Ste 205
Boston, MA 02210
https://roivant.com

Roivant Sciences, Inc. is a biotechnology company based in Boston, MA that is dedicated to revolutionizing the discovery, development, and commercialization of new medicines. They achieve this by building agile and focused companies called Vants, which employ technology across all stages of the drug development process. With a track record of 10 positive Phase 3 trials and 6 FDA approvals since 2019, Roivant Sciences is committed to advancing transformative therapies for autoimmune diseases and severe conditions.

Through their subsidiaries, such as Immunovant, Dermavant, and Priovant, Roivant Sciences aligns incentives to drive fast and high-quality execution, while also ensuring rigorous capital allocation. Their innovative approach and commitment to developing targeted therapies have earned them recognition, including being named to Fast Company's Best Workplaces for Innovators List. With a broad and differentiated pipeline of investigational drugs, Roivant Sciences is at the forefront of transforming the future of healthcare.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Blood derivatives, Drugs acting on the respiratory system

Kojin Therapeutics Inc

Elicio Therapeutics, Inc is a biotechnology company based in Boston, MA that focuses on developing novel immunotherapies for cancer treatment. The company utilizes cutting-edge technology and research to create innovative solutions for improving patient outcomes. With a dedicated team of experts, Elicio Therapeutics, Inc is committed to advancing the field of immunotherapy and making a meaningful impact in the fight against cancer. Their mission is to harness the power of the immune system to develop targeted therapies that address unmet medical needs. Generated from their business information
Business services, nec, nec, Drugs acting on the respiratory system

Akouos, Inc

Akouos, Inc. is a Boston-based precision genetic medicine company dedicated to developing innovative gene therapies aimed at restoring, improving, and preserving high-acuity hearing for individuals with disabling hearing loss. With a global focus on addressing the underlying causes of hearing loss, the company seeks to meet the significant unmet medical needs affecting 466 million people worldwide. At the core of Akouos's mission is a passionate team committed to collaboration and scientific excellence, emphasizing the importance of listening to one another. Their advanced technology platform is designed to bring the benefits of precision medicine to the inner ear, fostering advancements in hearing health. Generated from the website
Real estate managers, Drugs and drug proprietaries, Drugs acting on the respiratory system

Akcea Therapeutics, Inc

Akcea Therapeutics, Inc., based in Boston, MA, is a pioneering biopharmaceutical company dedicated to designing and developing highly selective small molecule medicines aimed at improving patient outcomes in oncology, immunology, and metabolic disorders. With a track record of success, the company applies leading-edge technologies and rigorous methodologies to enhance target selection and drug discovery processes. The organization's commitment to excellence is reflected in its expert leadership and collaborative culture, fostering a unique environment where talent is valued. Through meticulous attention to selectivity—whether in people, targets, or potential drug molecules—Akcea Therapeutics continues to push the boundaries of medical innovation. Generated from the website
United States›Massachusetts›Boston›Roivant Sciences, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.